Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Radiotherapy Dosage. Found 61 abstracts

no pagination
Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov;16(6):1144-51.
Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov;16(6):1144-51.
Jin L, Price RA, Wang L, Meyer J, Fan JJ, Ma CM. Dosimetric and delivery efficiency investigation for treating hepatic lesions with a MLC-equipped robotic radiosurgery-radiotherapy combined system. Med Phys. 2016 Feb;43(2):727-33.
Balamucki CJ, DeJesus R, Galloway TJ, Mancuso AA, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol. 2015 Jun;38(3):248-51.
Martin JM, Handorf EA, Price RA, Cherian G, Buyyounouski MK, Chen DY, Kutikov A, Johnson ME, Ma CC, Horwitz EM. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer. Medical Dosimetry. 2015 Jan;40(3):186-9.   PMCID: 4500753
Murphy CT, Heller S, Ruth K, Buyyounouski MK, Weinberg D, Uzzo RG, Plimack E, Kutikov A, Chen DY, Horwitz EM. Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques. Practical radiation oncology. 2015 May;5(3):e215-e222.   PMCID: Needs PMCID
Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology Biology Physics. 2015 Jan;91(1):116-23.   PMCID: 4385459
Xanthopoulos EP, Handorf E, Simone CB, Grover S, Fernandes AT, Sharma S, Corradetti MN, Evans TL, Langer CJ, Mitra N, Shah A, Apisarnthanarax S, Lin LL, Rengan R. Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. Practical radiation oncology. 2015 Jul;5(4):e355-63.
Chibani O, Ma CM. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators. Med Phys. 2014 May;41(5):051712.
Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, Hodi FS, Ibrahim N, Weiss SE, Kelly PJ, Floyd SR, Mahadevan A, Alexander BM. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiat Oncol. 2014 Jun;9:143.   PMCID: 4132230
Hossain M. Output trends, characteristics, and measurements of three megavoltage radiotherapy linear accelerators. J Appl Clin Med Phys. 2014 Jul 08;15(4):4783.   PMCID: 4393854
Shaikh T, Turaka A. Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy. Cancer Treat Rev. 2014 Dec;40(10):1215-20.
Vazquez Quino LA, Chen X, Fitzpatrick M, Shi C, Stathakis S, Gutierrez A, Esquivel C, Mavroidis P, Alkhatib H, Papanikolaou N. Patient specific pre-treatment QA verification using an EPID approach. Technol Cancer Res Treat. 2014 Feb;13(1):1-10.   PMCID: *
Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 2014 Sep;13(5):456-64.
Zaorsky NG, Doyle LA, Hurwitz MD, Dicker AP, Den RB. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?. Expert Rev Anticancer Ther. 2014 Jan;14(1):39-50.
Ma CM, Li J. Dose specification for radiation therapy: dose to water or dose to medium?. Phys Med Biol. 2011 May 21;56(10):3073-89.   PMCID: not NIH funded
Ma CM, Luxton G, Orton CG. Point/counterpoint: pulsed reduced dose rate radiation therapy is likely to become the treatment modality of choice for recurrent cancers. Med Phys. 2011 Sep;38(9):4909-11.   PMCID: not NIH funded
Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys. 2011 Jan;79(1):65-70.   PMCID: PMC3339153
Buyyounouski MK, Balter P, Lewis B, D'Ambrosio DJ, Dilling TJ, Miller RC, Schefter T, Tome W, Harris EE, Price RA, Konski AA, Wallner PE. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys. 2010 Sep;78(1):3-10.   PMCID: No funding
Anderson PR, Freedman G, Nicolaou N, Sharma N, Li T, Topham N, Morrow M. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates?. Int J Radiat Oncol Biol Phys. 2009 May;74(1):81-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Radiotherapy Dosage

Radiotherapy Dosage radiotherapy methods Male Computer-Assisted Radiotherapy Planning Female Aged adverse effects Middle Aged Adult Retrospective Studies pathology Brachytherapy 80 and over Aged Treatment Outcome Intensity-Modulated Radiotherapy instrumentation surgery radiation effects therapeutic use Follow-Up Studies Prostatic Neoplasms mortality Magnetic Resonance Imaging Local Neoplasm Recurrence Survival Rate Photons Lung Neoplasms Radiosurgery X-Ray Computed Tomography Ultrasonography Four-Dimensional Computed Tomography Patient Selection Combined Modality Therapy Antineoplastic Agents Non-Small-Cell Lung Carcinoma Kaplan-Meier Estimate Particle Accelerators Radiation Dosage Neoplasms Head and Neck Neoplasms Water Prostate cancer diagnostic imaging therapy Calibration etiology Thoracic Wall Three-Dimensional Imaging Endometrial Neoplasms Computer assisted dosimetry calculations Skin Neoplasms Endometrioid Carcinoma drug therapy Prognosis Endometrioid adenocarcinoma Neoplasm Staging Intracavitary brachytherapy Endometrial cancer radiography Monte Carlo Method Squamous Cell Carcinoma Breast Neoplasms Dose Fractionation Lung cancer Clinical Trials as Topic Capecitabine Salvage Therapy Proportional Hazards Models Liver Neoplasms Tumor Biomarkers Gastrointestinal Diseases Biological Models Radiometry Iridium Radioisotopes Spinal Cord Low-dose rate Robotics Stereotactic body radiotherapy Analysis of Variance Rib fracture Rectal Neoplasms Algorithms Brain Neoplasms Adenocarcinoma Radiotherapy Ulcerative Colitis Inflammatory Bowel Diseases Reoperation Peripheral Nerves Fluorouracil Mammaplasty Antineoplastic Combined Chemotherapy Protocols Postoperative Complications Penile Erection Biochemical control Treatment Failure Electrons Linear Models anatomy & histology Risk Factors Intensity-modulated radiation therapy Conformal Radiotherapy Neoplasm Invasiveness standards Disease-Free Survival Breast Implants secondary Prostate-Specific Antigen Movement utilization contraindications Cranial Irradiation trends Disease Management Esthetics Organ Sparing Treatments Recurrence Deoxycytidine Radiation-Sensitizing Agents administration & dosage Gastrostomy Lymph Node Excision Organ Size Radiation Protection Drug Administration Schedule Radiation Exposure analogs & derivatives Prostate Tumor Burden analysis Modified Radical Mastectomy Regression Analysis complications Chi-Square Distribution Crohn Disease Organoplatinum Compounds Neoadjuvant Therapy Respiratory-Gated Imaging Techniques Respiration Software Radiologic Technology Risk Chest wall toxicity Basal Cell Carcinoma Testicle dose Equipment Design Health Care Quality Assurance Esophageal Neoplasms Tissue Expansion Devices
Last updated on Wednesday, August 12, 2020